NDC 0228-3156

Buprenorphine

Buprenorphine

Buprenorphine is a Sublingual Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Buprenorphine Hydrochloride.

Product ID0228-3156_01763a3b-afc8-4551-b9d5-f8d8ff2801b8
NDC0228-3156
Product TypeHuman Prescription Drug
Proprietary NameBuprenorphine
Generic NameBuprenorphine
Dosage FormTablet
Route of AdministrationSUBLINGUAL
Marketing Start Date2015-02-19
Marketing CategoryANDA / ANDA
Application NumberANDA090819
Labeler NameActavis Pharma, Inc.
Substance NameBUPRENORPHINE HYDROCHLORIDE
Active Ingredient Strength2 mg/1
Pharm ClassesPartial Opioid Agonists [MoA],Partial Opioid Agonist [EPC]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0228-3156-03

30 TABLET in 1 BOTTLE (0228-3156-03)
Marketing Start Date2015-04-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0228-3156-09 [00228315609]

Buprenorphine TABLET
Marketing CategoryANDA
Application NumberANDA090819
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-19
Marketing End Date2015-02-19

NDC 0228-3156-03 [00228315603]

Buprenorphine TABLET
Marketing CategoryANDA
Application NumberANDA090819
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-04-10

NDC 0228-3156-73 [00228315673]

Buprenorphine TABLET
Marketing CategoryANDA
Application NumberANDA090819
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-19
Marketing End Date2015-02-19

Drug Details

Active Ingredients

IngredientStrength
BUPRENORPHINE HYDROCHLORIDE2 mg/1

OpenFDA Data

SPL SET ID:03819118-86f6-4329-adaf-4599e7b71f46
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 351265
  • 351264
  • UPC Code
  • 0302283156031
  • 0302283153030
  • Pharmacological Class

    • Partial Opioid Agonists [MoA]
    • Partial Opioid Agonist [EPC]

    NDC Crossover Matching brand name "Buprenorphine" or generic name "Buprenorphine"

    NDCBrand NameGeneric Name
    0093-3239BuprenorphineBuprenorphine
    0093-3600BuprenorphineBuprenorphine
    0093-3601BuprenorphineBuprenorphine
    0093-3602BuprenorphineBuprenorphine
    0093-3603BuprenorphineBuprenorphine
    0093-3656BuprenorphineBuprenorphine
    0093-3657BuprenorphineBuprenorphine
    0093-3658BuprenorphineBuprenorphine
    0093-3659BuprenorphineBuprenorphine
    0228-3153BuprenorphineBuprenorphine
    0228-3156BuprenorphineBuprenorphine
    70518-0711BuprenorphineBuprenorphine
    70518-1557BuprenorphineBuprenorphine
    70518-1625BuprenorphineBuprenorphine
    71335-0353BuprenorphineBuprenorphine
    71335-0950BUPRENORPHINEBUPRENORPHINE
    42858-586BuprenorphineBuprenorphine
    42858-750BuprenorphineBuprenorphine
    42858-502BUPRENORPHINEBUPRENORPHINE
    42858-501BUPRENORPHINEBUPRENORPHINE
    42858-353BuprenorphineBuprenorphine
    42858-839BuprenorphineBuprenorphine
    42858-493BuprenorphineBuprenorphine
    50090-2924BuprenorphineBuprenorphine
    55700-579BuprenorphineBuprenorphine
    55700-568BuprenorphineBuprenorphine
    58118-3156BuprenorphineBuprenorphine
    62756-459BuprenorphineBuprenorphine
    62756-460BuprenorphineBuprenorphine
    67046-994BuprenorphineBuprenorphine
    67046-995BuprenorphineBuprenorphine
    71335-1154BUPRENORPHINEBUPRENORPHINE
    70518-2218BUPRENORPHINEBUPRENORPHINE
    70518-2217BUPRENORPHINEBUPRENORPHINE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.